Ionis Pharmaceuticals | IONS - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
Agios Pharmaceuticals USD 1.6B 410M 2026-04
Alnylam Pharmaceuticals USD 40.54B 12B 2026-04
Arrowhead Research USD 9.02B 4.25B 2025-12
Astellas Pharma JPY 4.13T 430.55B 2026-04
BioCryst Pharmaceuticals USD 1.66B 64M 2025-12
BioMarin Pharmaceutical USD 11.42B 1.02B 2025-12
Cspc Pharmaceutical CNY 87.29B 19.74B 2025-12
Deva Holding AS TRY 17.54B 7.76B 2023-09
Divis Laboratories Ltd INR 1.7T 186.62B 2025-12
Esperion Therapeutics USD 885M 351M 2025-12
Exelixis USD 11.75B 959M 2025-12
Halozyme Therapeutics USD 7.91B 664M 2025-12
Ionis Pharmaceuticals USD 10.9B 1.55B 2026-04
Kangmei Pharma CNY 27.93B 1.73B 2025-09
Knight Therapeutics CAD 600.53M 14.56M 2025-12
Laboratorios Farma EUR 4.17B 917.16M 2026-03
Malin Corporation EUR 142.92M 19.65M 2026-02
Medical Developments International AUD 62.53M 563.29K 2025-12
Nektar Therapeutics USD 14.34B 13.48B 2026-04
Neuren Pharmaceuticals AUD 2.36B 606.56M 2025-12
Neurocrine Biosciences USD 14.14B 218M 2025-12
Novartis USD 231.75B 76B 2026-04
OPKO Health USD 967.3M 263.06M 2025-12
Organigram Holdings CAD 312.16M 66.64M 2025-12
Ovoca Bio EUR 6.12M 4.93M 2026-04
Pfizer USD 141.57B 6.48B 2025-12
Pharma Mar EUR 1.68B 330.24M 2026-04
PTC Therapeutics USD 5.26B 844M 2026-04
Qiagen NV USD 6.8B 1.47B 2026-04
Regeneron Pharmaceuticals USD 75.34B 6.35B 2026-04
Roche Holding CHF 266.34B 55.46B 2025-12
Sarepta Therapeutics USD 2.26B 238M 2025-12
Sartorius EUR 7.48B 6.76B 2026-04
Ultragenyx Pharmaceutical USD 2.22B 680M 2025-12
Vertex Pharmaceuticals USD 115.03B 14.61B 2025-12
Zealand Pharma A/S 33.35B 0 2026-04
Zz Pientze Pharmaceu CNY 86.61B 4.56B 2026-04